Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma-Reference-Cited by-同舟云学术

Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma

Published:2014-07-08 Issue:9 Volume:69 Page:1198-1204
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Kupczyk M.¹²,Dahlén B.¹,Sterk P. J.³,Nizankowska-Mogilnicka E.⁴,Papi A.⁵,Bel E. H.³,Chanez P.⁶,Howarth P. H.⁷,Holgate S. T.⁷,Brusselle G.⁸,Siafakas N. M.⁹,Gjomarkaj M.¹⁰,Dahlén S.-E.¹,

Affiliation:

1. Karolinska Institutet; Stockholm Sweden

2. Medical University of Lodz; Lodz Poland

3. University of Amsterdam; Amsterdam the Netherlands

4. Jagiellonian University; Krakow Poland

5. University of Ferrara; Ferrara Italy

6. University of Marseille; Marseille France

7. University of Southampton; Southampton UK

8. Ghent University Hospital; Ghent Belgium

9. University of Crete; Heraklion Greece

10. Italian National Research Council; Palermo Italy

Funder

The Fifth and Sixth Framework Programmes

The Fifth and Sixth Framework Programmes of the European Union

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference24 articles.

1. Asthma phenotypes: the evolution from clinical to molecular approaches;Wenzel;Nat Med,2012

2. US and European severe asthma cohorts: what can they teach us about severe asthma?;Kupczyk;J Intern Med,2012

3. T-helper type 2-driven inflammation defines major subphenotypes of asthma;Woodruff;Am J Respir Crit Care Med,2009

4. Cluster analysis and clinical asthma phenotypes;Haldar;Am J Respir Crit Care Med,2008

5. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes;Hastie;J Allergy Clin Immunol,2010

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapsing Eosinophilia in a Severe Allergic Asthma Patient on Biological Therapy;Journal of Clinical Medicine;2024-06-11

2. Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types;Journal of Asthma and Allergy;2024-03

3. Promising treatment biomarkers in asthma;Frontiers in Drug Safety and Regulation;2023-11-07

4. Molecular T2 asthma phenotypes are stable but heterogeneous: the usefulness of periostin for endotyping;Frontiers in Allergy;2023-09-08

5. Cost-effectiveness of tezepelumab in Canada for severe asthma;Journal of Medical Economics;2023-07-17